FDA Inspection 743217 — Salutas Pharma GmbH

Salutas Pharma GmbH — FEI 3003144208

The FDA completed an inspection of Salutas Pharma GmbH on Jul 21, 2011 in Barleben. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jul 21, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barleben (Germany)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.